Showcase your pioneering research on the global stage and seize the opportunity to join the prestigious TCT^® Faculty!

Challenging Cases

Physicians and fellows from around the world, submit your most challenging coronary, endovascular, and structural heart disease cases. The best cases will be chosen by the course directors for presentation.

Guidelines: Character limit is 2,450 total for case summary, history, diagnostic tests, procedure, conclusion, comments. PowerPoint slide presentation highlighting your case is optional. Images: 10 MB. Video formats accepted: 30 MB mpeg, wmv, avi, mov, mpg, mp4.

Images will reduce your character limit by 600.

Tables will reduce your character limit by 300.

Notification: Accepted presenters will be notified in September.

Abstracts

Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to interventional cardiology, endovascular medicine, or structural heart disease. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented or published elsewhere.

Note: Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.

Guidelines: Please ensure that your abstract submission undergoes thorough grammatical checking to ensure it is publication-ready if accepted. Additionally, verify that all study information, including tables and images, is correctly uploaded and displayed on the submission site.

We strongly encourage you to submit your work in both the abstracts and late-breaking categories. Please make sure to check the box indicating that you've submitted to both categories accordingly. This ensures that your research has the opportunity to be considered for both presentation formats, increasing the chances of its visibility and impact at TCT^® 2024.

Character limit is 2,200, including spaces (approximately 300-350 words).

Images will reduce your character limit by 600.

Tables will reduce your character limit by 300.

Notification: Accepted presenters will be notified in September.

Innovation Sessions and TCT^® Shark Tank Innovation Competition

Innovation Sessions

Submit your novel technologies relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease. Selected emerging technologies will be presented at TCT^® 2024.

TCT^® Shark Tank Innovation Competition

Enter the Shark Tank! The annual TCT^® meeting is the preeminent platform for concept-stage presentations of novel technologies in interventional cardiovascular medicine. Submit concept-stage novel technologies in interventional cardiovascular medicine for a chance to present to a panel of expert judges and compete for an award of $200,000 provided by the Jon DeHaan Foundation.

Your submission must be relevant to the monitoring, diagnosis, or treatment of coronary, endovascular, or structural heart disease and meet all three of the following criteria:

• Addresses an unmet clinical need
• Has preliminary patent application filed
• Includes preclinical or early human clinical data

Guidelines: Describe clinical indication for innovative device or technology. Character limit 2,450, including spaces. Submit 15-20 PowerPoint slides covering aspects of the technology.

Notification: Accepted presenters will be notified in mid-September.

Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Younger than 40? Committed to academic and research excellence and have the accomplishments to demonstrate it? Apply for this Young Investigator Award!

The Linnemeier Award is designed to encourage young physicians in their pursuit of a life-long commitment to joint clinical and academic excellence. This award recognizes clinical and academic excellence in interventional cardiovascular medicine and aims to stimulate the continued commitment and dedication to both outstanding patient care and ongoing academic inquiry by young investigators.

The three finalists will become faculty at TCT^® 2024. The winner will be announced at the conference and will receive the award along with a $10,000 scholarship on the podium at TCT^® 2024.

Eligibility: We encourage both international and US-based applicants. Candidates for this award must be:

• Younger than 40 years old at the start of TCT^® 2024 (October 27, 2024), but excluding individuals who have attained the rank of associate or full professor. Applicants over the age of 40 need not apply.
• Specializing in interventional cardiovascular medicine (interventional cardiology, endovascular medicine, structural heart disease, pathology, etc.).

Guidelines: Required documents: CV, personal statement, clinical accomplishments, letters of recommendation, and supplemental information.

Notification: Accepted presenters will be notified mid-September.

Late-Breaking Clinical Trials and Science/First-in-Human & Early Feasibility Studies

Late-Breaking Clinical Trials and Science are typically:

• First-time presentations of first-in-human experiences with novel devices or drugs.
• Primary or important secondary endpoint results of prospective randomized clinical trials.
• Large-scale, impactful single-/multicenter registries.

If your submission is accepted, you will present it at TCT^® 2024 and will provide presentation slides a week prior to the conference. In addition, a few presentations will be chosen for the press conferences scheduled on the same day.

Embargo: The content of accepted late-breaking clinical trials and science is strictly embargoed until time of presentation.

Non-Qualifying Submissions: Please note that the following rarely qualify as late-breaking clinical trial submissions and instead, should be submitted as abstracts or to call for innovation: preclinical studies, early first-in-human device studies, and meta-analyses.

If you are uncertain about whether your research qualifies for LBCT/S consideration, please also submit it as an abstract. Doing so will not diminish your chances for LBCT/S selection but will enhance the possibility of your work being presented at TCT^®2024.

Guidelines: Total character limit is 3,250, including spaces (primary endpoints: 550-character limit; secondary endpoints: 550-character limit; funding sources: 500 character limit). Upload .png or .jpg files only. Images will reduce your character limit by 600. Tables will reduce your character limit by 300.

We strongly encourage you to submit your work in both the late-breaking and abstract categories. Please make sure to check the box indicating that you've submitted to both categories accordingly. This ensures that your research has the opportunity to be considered for both presentation formats, increasing the chances of its visibility and impact at TCT^® 2024.

Notification: Accepted presenters will be notified in mid-September.

To reset your Call for Science password, please log in to https://callforscience.crf.org/#/access/signin/ and select the "Forgot Password" option.

Please note that only one Call for Science email account should be used. Kindly refrain from using or creating multiple accounts.

Yes, entries must be original research but may include portions of abstracts and/or manuscripts presented elsewhere.

Unfortunately, we are unable to accept submissions after the final submission deadline has elapsed.

Yes, you can make changes to your submission at any time before the submission deadline.

Please access https://callforscience.crf.org/#/access/signin/ to manage your submission. You can add authors or update information within the authors' profiles by visiting your submission and selecting the "Authors" tab. To designate a new presenter or author, simply check the "presenter" box next to the respective name.

TCT^® 2024 is exclusively an in-person event, and virtual participation is not offered.